Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera Q2 Operating Loss Narrows To SEK 15.4 Million

Aug 19 (Reuters) - Kancera AB  KANC.ST :
    * Q2 OPERATING LOSS SEK 15.4 MILLION VERSUS LOSS SEK 18.2
MILLION
YEAR AGO
    * Q2 NET SALES SEK 0 MILLION

Source text for Eikon:  ID:nMFN72z5d1 
Further company coverage:  KANC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Novakand Pharma AB

See all news